MedPath

Universitaire Ziekenhuizen Leuven

Universitaire Ziekenhuizen Leuven logo
🇧🇪Belgium
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.uzleuven.be

The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis

Completed
Conditions
Chronic Kidney Disease
First Posted Date
2007-02-09
Last Posted Date
2009-03-05
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Target Recruit Count
62
Registration Number
NCT00433264
Locations
🇧🇪

Universitaire Ziekenhuizen Leuven, Leuven, Vlaams-Brabant, Belgium

Protein-bound Uremic Retention Solutes and Long Nocturnal Hemodialysis: a Longitudinal Analysis

Completed
Conditions
End Stage Kidney Disease
Interventions
Procedure: hemodialysis
First Posted Date
2007-01-01
Last Posted Date
2016-05-13
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Target Recruit Count
38
Registration Number
NCT00417339
Locations
🇦🇺

Monash Medical Centre, Clayton, Victoria, Australia

🇦🇺

Geelong Hospital, Geelong, Victoria, Australia

🇧🇪

Universitaire Ziekenhuizen Leuven, Leuven, Brabant, Belgium

and more 1 locations

Protein-Bound Uremic Retention Solutes in Long Nocturnal Hemodialysis

Completed
Conditions
End Stage Renal Disease
Interventions
Procedure: hemodialysis
First Posted Date
2006-12-29
Last Posted Date
2009-03-05
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Target Recruit Count
120
Registration Number
NCT00417105
Locations
🇦🇺

Geelong Hospital, Geelong, Victoria, Australia

🇧🇪

Virga Jesse Ziekenhuis, Hasselt, Limburg, Belgium

🇧🇪

Universitaire Ziekenhuizen Leuven, Leuven, Vlaams-Brabant, Belgium

and more 1 locations

Citrate Anticoagulation vs. Heparin-Coated Dialyzers

Phase 3
Completed
Conditions
Dialysis
First Posted Date
2006-11-03
Last Posted Date
2006-11-03
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Target Recruit Count
33
Registration Number
NCT00395824
Locations
🇧🇪

University Hopsital Leuven, Leuven, Belgium

A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM)

Phase 2
Completed
Conditions
Myelofibrosis
Myeloid Metaplasia
Interventions
First Posted Date
2006-02-06
Last Posted Date
2014-12-09
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Target Recruit Count
17
Registration Number
NCT00287261
Locations
🇮🇱

RAMBAM Medical Center and Technion, Haifa, Israel

🇦🇺

Cancer Care Services, Brisbane, Queensland, Australia

🇫🇷

Hopital Avicenne and Paris 13 University, Bobigny, France

and more 3 locations

Caelyx Adjuvant in Elderly Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Elderly
First Posted Date
2006-01-31
Last Posted Date
2014-12-09
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Target Recruit Count
16
Registration Number
NCT00284336
Locations
🇧🇪

UZ gent, Gent, Belgium

🇧🇪

UH gasthuisberg, Leuven, Belgium

SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer

Phase 2
Completed
Conditions
Metastatic Breast Cancer
Interventions
First Posted Date
2005-12-26
Last Posted Date
2022-11-22
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Target Recruit Count
19
Registration Number
NCT00270413
Locations
🇧🇪

Liege sart-tilman, Liege, Belgium

🇧🇪

Imelda Bonheiden, Bonheiden, Belgium

🇧🇪

ZOL, Hasselt, Belgium

and more 10 locations

Prevention of Docetaxel Induced Dacryostenosis

Phase 1
Completed
Conditions
Epiphora
Interventions
Drug: Maxidex; Lacrystat
First Posted Date
2005-12-19
Last Posted Date
2010-06-28
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Target Recruit Count
20
Registration Number
NCT00266838
Locations
🇧🇪

Mombaerts, Leuven, Belgium

Bone Marrow-Derived Stem Cell Transfer in Acute Myocardial Infarctions

Phase 2
Completed
Conditions
Myocardial Infarction
First Posted Date
2005-12-12
Last Posted Date
2013-01-17
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Target Recruit Count
68
Registration Number
NCT00264316
Locations
🇧🇪

Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium

Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
First Posted Date
2005-11-21
Last Posted Date
2014-12-09
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Target Recruit Count
117
Registration Number
NCT00256360
Locations
🇧🇪

UZ Gasthuisberg Leuven, Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath